Literature DB >> 24863690

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib.

V Vergote1, D Dierickx, A Janssens, G Verhoef, T Tousseyn, P Vandenberghe, P Wolter, M Delforge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24863690     DOI： 10.1007/s00277-014-2104-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

Review 1.  Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature.

Authors:  Elisabetta Di Liso; Natale Pennelli; Gigliola Lodovichetti; Cristina Ghiotto; Angelo Paolo Dei Tos; PierFranco Conte; Laura Bonanno
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Authors:  Michael R Grever; Omar Abdel-Wahab; Leslie A Andritsos; Versha Banerji; Jacqueline Barrientos; James S Blachly; Timothy G Call; Daniel Catovsky; Claire Dearden; Judit Demeter; Monica Else; Francesco Forconi; Alessandro Gozzetti; Anthony D Ho; James B Johnston; Jeffrey Jones; Gunnar Juliusson; Eric Kraut; Robert J Kreitman; Loree Larratt; Francesco Lauria; Gerard Lozanski; Emili Montserrat; Sameer A Parikh; Jae H Park; Aaron Polliack; Graeme R Quest; Kanti R Rai; Farhad Ravandi; Tadeusz Robak; Alan Saven; John F Seymour; Tamar Tadmor; Martin S Tallman; Constantine Tam; Enrico Tiacci; Xavier Troussard; Clive S Zent; Thorsten Zenz; Pier Luigi Zinzani; Brunangelo Falini
Journal:  Blood       Date:  2016-11-30       Impact factor: 22.113

3.  BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.

Authors:  Svetlana A Protsenko; Anna I Semionova; Yuri I Komarov; Svetlana N Aleksakhina; Alexandr O Ivantsov; Aglaya G Iyevleva; Evgeny N Imyanitov
Journal:  Invest New Drugs       Date:  2015-08-20       Impact factor: 3.850

4.  Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

Authors:  Enrico Tiacci; Jae H Park; Luca De Carolis; Stephen S Chung; Alessandro Broccoli; Sasinya Scott; Francesco Zaja; Sean Devlin; Alessandro Pulsoni; Young R Chung; Michele Cimminiello; Eunhee Kim; Davide Rossi; Richard M Stone; Giovanna Motta; Alan Saven; Marzia Varettoni; Jessica K Altman; Antonella Anastasia; Michael R Grever; Achille Ambrosetti; Kanti R Rai; Vincenzo Fraticelli; Mario E Lacouture; Angelo M Carella; Ross L Levine; Pietro Leoni; Alessandro Rambaldi; Franca Falzetti; Stefano Ascani; Monia Capponi; Maria P Martelli; Christopher Y Park; Stefano A Pileri; Neal Rosen; Robin Foà; Michael F Berger; Pier L Zinzani; Omar Abdel-Wahab; Brunangelo Falini; Martin S Tallman
Journal:  N Engl J Med       Date:  2015-09-09       Impact factor: 91.245

Review 5.  Recent advances in understanding and managing hairy cell leukemia.

Authors:  Tobias Roider; Brunangelo Falini; Sascha Dietrich
Journal:  F1000Res       Date:  2018-04-27

Review 6.  Skin changes in hairy cell leukemia.

Authors:  Ewa Robak; Dorota Jesionek-Kupnicka; Tadeusz Robak
Journal:  Ann Hematol       Date:  2020-11-20       Impact factor: 3.673
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.